Literature DB >> 27247519

Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients.

Young Suk Chang1, Jae Hui Kim2, Jong Woo Kim2, Tae Gon Lee2, Chul Gu Kim1.   

Abstract

PURPOSE: To evaluate the efficacy of an optical coherence tomography (OCT)-based diagnosis of polypoidal choroidal vasculopathy (PCV) in Korean patients.
METHODS: This retrospective, observational case series included 263 eyes of 263 patients (147 eyes with PCV and 116 eyes with typical exudative, age-related macular degeneration [AMD]) who had been diagnosed with treatment naïve exudative AMD. Eyes with three or more of the following OCT findings were diagnosed with PCV: multiple retinal pigment epithelial detachment (RPED), a sharp RPED peak, an RPED notch, a hyporeflective lumen representing polyps, and hyperreflective intraretinal hard exudates. The OCT-based diagnosis was compared with the gold-standard indocyanine green angiography-based method. The sensitivity and specificity of the OCT-based diagnosis was also estimated. An additional analysis was performed using a choroidal thickness criterion. Eyes with a subfoveal choroidal thickness greater than 300 µm were also diagnosed with PCV despite having only two OCT features.
RESULTS: In eyes with PCV, three or more OCT features were observed in 126 of 147 eyes (85.7%), and the incidence of typical exudative AMD was 16 of 116 eyes (13.8%). The sensitivity and specificity of an OCT-based diagnosis were 85.7% and 86.2%, respectively. After applying the choroidal thickness criterion, the sensitivity increased from 85.7% to 89.8%, and the specificity decreased from 86.2% to 84.5%.
CONCLUSIONS: The OCT-based diagnosis of PCV showed a high sensitivity and specificity in Korean patients. The addition of a choroidal thickness criterion improved the sensitivity of the method with a minimal decrease in its specificity.

Entities:  

Keywords:  Choroidal neovascularization; Diagnosis; Macular degeneration; Optical coherence tomography; Polypoidal choroidal vasculopathy

Mesh:

Year:  2016        PMID: 27247519      PMCID: PMC4878980          DOI: 10.3341/kjo.2016.30.3.198

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  22 in total

1.  Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Yu Kawashima; Akio Oishi; Akitaka Tsujikawa; Kenji Yamashiro; Masahiro Miyake; Naoko Ueda-Arakawa; Munemitsu Yoshikawa; Ayako Takahashi; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-13       Impact factor: 3.117

2.  Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy.

Authors:  Gabriella De Salvo; Sara Vaz-Pereira; Pearse A Keane; Adnan Tufail; Gerald Liew
Journal:  Am J Ophthalmol       Date:  2014-08-22       Impact factor: 5.258

3.  Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.

Authors:  Adrian H C Koh; Lee-Jen Chen; Shih-Jen Chen; Youxin Chen; Anantharam Giridhar; Tomohiro Iida; Hakyoung Kim; Timothy Yuk Yau Lai; Won Ki Lee; Xiaoxin Li; Tock Han Lim; Paisan Ruamviboonsuk; Tarun Sharma; Shibo Tang; Mitsuko Yuzawa
Journal:  Retina       Date:  2013-04       Impact factor: 4.256

4.  Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging.

Authors:  Gabriel Coscas; Kenji Yamashiro; Florence Coscas; Umberto De Benedetto; Akitaka Tsujikawa; Masahiro Miyake; Chui Ming Gemmy Cheung; Tien Yin Wong; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2014-05-17       Impact factor: 5.258

5.  Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumab.

Authors:  Masaaki Saito; Mariko Kano; Kanako Itagaki; Yasuharu Oguchi; Tetsuju Sekiryu
Journal:  Retina       Date:  2014-11       Impact factor: 4.256

6.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

7.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

8.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

9.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

10.  Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.

Authors:  Akiyuki Kawamura; Mitsuko Yuzawa; Ryusaburo Mori; Miho Haruyama; Koji Tanaka
Journal:  Acta Ophthalmol       Date:  2013-07-15       Impact factor: 3.761

View more
  5 in total

1.  [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy].

Authors:  Yi Zhang; Jing Yao; Xiao-Hua Wang; Lin Zhao; Li-Jun Wang; Jian-Ming Wang; Ai-Yi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  Diagnostic Value of Spectral-Domain Optical Coherence Tomography for Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis.

Authors:  Yang Jiang; Shixin Qi
Journal:  Front Med (Lausanne)       Date:  2022-06-15

3.  Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy.

Authors:  Jingyuan Yang; Mingzhen Yuan; Erqian Wang; Song Xia; Youxin Chen
Journal:  BMC Ophthalmol       Date:  2019-11-16       Impact factor: 2.209

4.  Polypoidal Choroidal Vasculopathy in Congolese Patients.

Authors:  Nelly N Kabedi; David L Kayembe; Gloria M Elongo; Jean-Claude Mwanza
Journal:  J Ophthalmol       Date:  2020-01-18       Impact factor: 1.909

Review 5.  Optical coherence tomography in diagnosing polypoidal choroidal vasculopathy. Looking into the future: a systematic review and meta-analysis.

Authors:  Annisa C Permadi; Ari Djatikusumo; Gitalisa Andayani Adriono
Journal:  Int J Retina Vitreous       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.